skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Plant-derived bioactive compounds in colon cancer treatment: An updated review

Biomedicine & pharmacotherapy, 2022-09, Vol.153, p.113384-113384, Article 113384 [Peer Reviewed Journal]

2022 The Authors ;info:eu-repo/semantics/openAccess ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2022.113384

Full text available

Citations Cited by
  • Title:
    Plant-derived bioactive compounds in colon cancer treatment: An updated review
  • Author: Esmeeta, Akanksha ; Adhikary, Subhamay ; Dharshnaa, V. ; Swarnamughi, P. ; Ummul Maqsummiya, Z. ; Banerjee, Antara ; Pathak, Surajit ; Duttaroy, Asim K.
  • Subjects: Anti-cancer mechanism ; Carcinogenesis ; Chemoprevention ; Colon cancer ; Plant-derived compounds
  • Is Part Of: Biomedicine & pharmacotherapy, 2022-09, Vol.153, p.113384-113384, Article 113384
  • Description: Colon cancer is the third most predominant cancer caused by genetic, environmental and nutritional factors. Plant-based compounds are very well known to regress colon cancer in many ways, like delaying tumor growth, managing chemotherapy and radiation therapy side-effects, and working at the molecular levels. Medicinal plants contain many bioactive phytochemicals such as flavonoids, polyphenol compounds, caffeic acid, catechins, saponins, polysaccharides, triterpenoids, alkaloids, glycosides, phenols, quercetin, luteolin, kaempferol and luteolin glycosides, carnosic acid, oleanolic acid, rosmarinic acid, emodin, and eugenol and anthricin. These bioactive compounds can reduce tumor cell proliferation via several mechanisms, such as blocking cell cycle checkpoints and promoting apoptosis through activating initiator and executioner caspase. Traditional medicines have been used globally to treat cancers because of their anti-cancer effects, antioxidant properties, anti-inflammatory properties, anti-mutagenic effects, and anti-angiogenic effects. In addition, these medicines effectively suppress early and intermediate stages of carcinogenesis when administered in their active and pure form. However, traditional medicine is not very popular due to some critical challenges. These include poor solubility and absorption of these compounds, intellectual property-related issues, involvement of drug synergism, absence of drug-likeness, and unsure protocols for their extraction from the plant source. Using bioactive compounds in colon cancer has equal advantages and limitations. This review highlights the benefits and challenges of using bioactive compounds derived from plants for colon cancer. We have also discussed using these compounds to target cancer stem cell self-renewal, its effects on cancer cell metabolism, safety parameters, easy modulation, and their bioavailability. [Display omitted] •Bioactive compounds suppress carcinogenesis at various stages of colon cancer.•Bioactive compounds can induce apoptosis and cell cycle arrest.•Bioactive compounds have anti-inflammatory and anti-oxidant activities.•Bioactive compounds modulate the JNK, STAT, PI3K/AKT/mTOR and MAPK pathways.•Bioactive compounds have lack drug-likeness and low bioavailability.
  • Publisher: Elsevier Masson SAS
  • Language: English;Norwegian
  • Identifier: ISSN: 0753-3322
    EISSN: 1950-6007
    DOI: 10.1016/j.biopha.2022.113384
  • Source: NORA Norwegian Open Research Archives
    DOAJ Directory of Open Access Journals
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait